₹35,000 crore for vaccination in the budget and she has assured that it could be increased if required.He said two vaccines -- Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech -- have been approved for emergency use authorisation.Besides these, work is in progress on seven vaccines.
Of the seven, three vaccines are in phase 3 clinical trial stage. Two vaccines are in phase 1 and 2 clinical trial stages and the remaining two are in advanced pre-clinical stage.He said India has received requests for vaccines from 22 countries.
These countries include Afghanistan, Algeria, Bangladesh, Bhutan, Brazil, Egypt, Kuwait, Maldives, Mauritius, Morocco, Mongolia, Myanmar, Nepal, Nicaragua, Oman,.
Read more on livemint.com